Lack of evidence for a reduction in the efficacy of subcutaneous BCG vaccination in mice infected with nontuberculous mycobacteria
- 1 March 1986
- Vol. 67 (1) , 41-46
- https://doi.org/10.1016/0041-3879(86)90030-9
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Does infection with environmental mycobacteria suppress the protective response to subsequent vaccination with BCG?Tubercle, 1985
- Species level identification of non-tuberculous mycobacteria from South Indian BCG trial area during 1981Tubercle, 1985
- Passive transfer of tuberculin sensitivity from anergic miceInfection and Immunity, 1984
- Acquired immunity to heavy infection with Mycobacterium bovis Bacillus Calmette-Guérin and its relationship to the development of nonspecific unresponsiveness in vitroCellular Immunology, 1984
- Efficacy of Mycobacterium bovis BCG vaccination in mice undergoing prior pulmonary infection with atypical mycobacteriaInfection and Immunity, 1984
- Immune response to atypical mycobacteria: immunocompetence of heavily infected mice measured in vivo fails to substantiate immunosuppression data obtained in vitroInfection and Immunity, 1984
- Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients.The Journal of Experimental Medicine, 1983
- Infection with Mycobacterium avium-intracellulare and the Protective Effects of Bacille Calmette-GuerinThe Journal of Infectious Diseases, 1982
- BCG vaccination and non-tuberculous mycobacteriaTubercle, 1981
- The effect of two distinct forms of cell-mediated response to mycobacteria on the protective efficacy of BCGTubercle, 1981